<- Go home

Added to YB: 2025-04-15

Pitch date: 2025-03-31

MCK [neutral]

McKesson Corporation

+27.2%

current return

Author Info

No bio for this author

Company Info

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.

Market Cap

$108.3B

Pitch Price

$673.57

Price Target

N/A

Dividend

0.37%

EV/EBITDA

17.71

P/E

25.45

EV/Sales

0.29

Sector

Health Care Providers and Services

Category

growth

Show full summary:
Conventum-Alluvium Global Fund Portfolio Holding: McKesson Corporation

MCK (holding update): Drug distributor +18.2%. Guidance upgraded, acquired PRISM Vision (1,890 providers, 91 offices). Ophthalmology joins Oncology as complementary biz. Sold 2 Canadian ops. 12-14% LT EPS growth. Trading 25% above valuation, but consistently conservative estimates. 6.9% of Fund.

Read full article (1 min)